New York 2023-2024 Regular Session

New York Senate Bill S08991

Introduced
4/8/24  

Caption

Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agents approved by the federal food and drug administration.

Companion Bills

NY A08075

Same As Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agent approved by the federal food and drug administration.

Previously Filed As

NY S04150

Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agents approved by the federal food and drug administration.

NY A08075

Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agent approved by the federal food and drug administration.

NY A00265

Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agent approved by the federal food and drug administration.

NY HB1121

Public Health - Opioids and Opioid Overdose Reversal Drugs - Information

NY HB05053

An Act Concerning Opioids And Access To Overdose Reversal Drugs.

NY HB358

AN ACT relating to opioid overdose reversal agents.

NY H2217

Relative to opioid reversal drugs

NY HB1174

Public schools; authorize to have a supply of FDA-approved opioid reversal agents on premises to counter opioid overdose.

NY HB572

Public Health - Opioid Overdose Reversal Drugs

NY SB793

Public Health - Opioid Overdose Reversal Drugs

Similar Bills

No similar bills found.